Dr. Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and Professor in the Department of Urologic Sciences at the University of British Columbia. He received his undergraduate degree from the University of British Colombia in Vancouver and his medical degree from Johannes Gutenberg University in Mainz, Germany. He completed his urologic training at the University of Washington in Seattle and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas. Dr. Black has a clinical subspecialty interest in bladder cancer. He also maintains a grant-funded translational research program in urothelial carcinoma with a focus on genomic analysis of response to chemotherapy, mechanisms of resistance to chemotherapy, and novel targeted therapies for bladder cancer. For example, one of his main laboratory projects relates to Notch signaling in bladder cancer and how to modulate this pathway for therapeutic purposes. He is an active clinical trialist in his field and is currently leading a cooperative group trial testing an immune checkpoint inhibitor in non-muscle invasive bladder cancer. Dr. Black has authored >180 peer-reviewed publications and his scientific work has been published in >300 abstracts at national and international meetings. Dr. Black has served as grant reviewer for multiple international funding agencies including Cancer Research UK, the Congressionally Directed Medical Research Program (CDMRP), and most of the main Canadian funding organizations. He is an ad hoc journal reviewer for 27 journals, and serves as member of Editorial Boards for Urologic Oncology, PLOS ONE, World Journal of Urology and Journal of Urology. He has received awards for peer review from European Urology (2013), Journal of Urology (2010, 2011, 2015) and the Canadian Urological Association Journal (2016). Dr. Black has received a number of awards including Best Clinical Paper Published in Literature by the European Association of Urology (2016), the David A. Swanson Distinguished Alumnus Award from MD Anderson Cancer Center (2017) and the Distinguished Achievement Award for Excellence in Clinical or Applied Research by University of British Colombia Faculty of Medicine (2013). He serves on the Board of Directors of the Société Internationale d'Urologie and is General Secretary of the International Bladder Cancer Network.
07:30 - 09:00
|Poster Session — Posters 2: Bladder Cancer||QCCC - 202|
07:00 - 10:00
|Hands-On Course — CUA Accredited Hands-on-Course #3: MRI and Targeted Biopsy||QCCC - 205 C|